# EDGAR Filing Document

**Accession Number:** 0001517681
**File Stem:** 0001493152-26-007520
**Filing Date:** 2026-2
**Character Count:** 2156
**Document Hash:** 90a82ff392645038e129131b325137cd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-007520.hdr.sgml**: 20260528

**ACCESSION NUMBER**: 0001493152-26-007520

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260220

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Propanc Biopharma, Inc.
- **CENTRAL INDEX KEY:** 0001517681
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 330662986
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 302/6 BUTLER STREET
- **CITY:** CAMBERWELL, VICTORIA
- **STATE:** C3
- **ZIP:** 3124
- **BUSINESS PHONE:** 61-03-9882-0780

**MAIL ADDRESS:**
- **STREET 1:** 302/6 BUTLER STREET
- **CITY:** CAMBERWELL, VICTORIA
- **STATE:** C3
- **ZIP:** 3124

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Propanc Health Group Corp
- **DATE OF NAME CHANGE:** 20110408

February 20, 2026

United States Securities and Exchange Commission

Division of Corporation Finance

Attn: Jimmy McNamara

100 F Street, N.E.

Washington, DC 20549

---

| | |
|:---|:---|
| **Re:** | **Propanc Biopharma, Inc.** |
|  | **Amendment No. 1 to Registration Statement on Form S-1** |
|  | **Filed February 19, 2026** |
|  | **File No. 333-293147** |

---

Ladies and Gentlemen:

The undersigned registrant (the "Registrant") hereby requests that the Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on February 24, 2026 at 12:00 p.m. Eastern Standard Time, or as soon thereafter as practicable.

The Registrant authorizes Chase Chandler of Brunson Chandler & Jones, PLLC, outside counsel to the Registrant, to verbally alter the requested date and time of effectiveness of the Registration Statement with the Commission. Please call Mr. Chandler at (801) 303-5772 with any questions.

Very truly yours,

---

| | |
|:---|:---|
| **Propanc Biopharma, Inc.** |  |
| */s/ James Nathanilesz* | |
| James Nathanilesz |  |
| Chief Executive Officer |  |

---